Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | ABL1 | P00519 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | PKM | P14618 | 1/20 | 1.00 |
| ▸ | IDE | P14735 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | RIN1 | Q13671 | 1/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 1.00 |
| ▸ | HLCS | P50747 | 6/20 | 0.69 |
| ▸ | CA12 | O43570 | 7/20 | 0.56 |
| ▸ | CA1 | P00915 | 7/20 | 0.56 |
| ▸ | CA2 | P00918 | 7/20 | 0.56 |
| ▸ | CA9 | Q16790 | 7/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biotin SCHEMBL826595 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL5376391 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL36572 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL9841217 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL410686 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL59420 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL23055065 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL20547409 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL22943835 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL3384633 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117568449-A | Compositions and methods for sample processing | 10X基因组学有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-110592182-B | Compositions and methods for sample processing | 10X基因组学有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-117136306-A | In vitro cell-based assays for predicting pharmacokinetics and brain permeability of biological agents | 基因泰克公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-112126675-B | Method and system for preparing nucleic acid sequencing library and library prepared by using same | 10X基因组学有限公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-107532211-B | Method for analyzing biomolecule using external biomolecule as standard substance and kit therefor | 金圣千 | 2022-08-23 | — | — | CN | disclosed |
| US-20210401995-A1 | TECHNIQUES FOR ENHANCING THE SELECTIVITY AND EFFICACY OF ANTIMICROBIAL AND ANTICANCER POLYMER AGENTS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2021-12-30 | — | — | US | disclosed |
| US-11167036-B2 | Techniques for enhancing the selectivity and efficacy of antimicrobial and anticancer polymer agents | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-11-09 | — | — | US | disclosed |
| CN-112126675-A | Method and system for preparing nucleic acid sequencing library and library prepared by using same | 10X基因组学有限公司 | 2020-12-25 | — | — | CN | disclosed |
| CN-107427808-B | Method and system for preparing nucleic acid sequencing library and library prepared by using same | 10X基因组学有限公司 | 2020-10-23 | — | — | CN | disclosed |
| US-20200164080-A1 | TECHNIQUES FOR ENHANCING THE SELECTIVITY AND EFFICACY OF ANTIMICROBIAL AND ANTICANCER POLYMER AGENTS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-05-28 | — | — | US | disclosed |
| CN-110592182-A | Compositions and methods for sample processing | 10X基因组学有限公司 | 2019-12-20 | — | — | CN | disclosed |
| CN-105492607-B | Compositions and methods for sample processing | 10X基因组学有限公司 | 2019-07-02 | — | — | CN | disclosed |
| CN-107427808-A | Method and system for preparing nucleic acid sequencing library and library prepared by using same | 10X基因组学有限公司 | 2017-12-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210401995-A1 | TECHNIQUES FOR ENHANCING THE SELECTIVITY AND EFFICACY OF ANTIMICROBIAL AND ANTICANCER POLYMER AGENTS | BTD, HLCS, CD47 | TDP1 3809/4885MEN1 2632/4885ABL1 754/4885 |
| US-20200164080-A1 | TECHNIQUES FOR ENHANCING THE SELECTIVITY AND EFFICACY OF ANTIMICROBIAL AND ANTICANCER POLYMER AGENTS | BTD, HLCS, CD47 | TDP1 3809/4885MEN1 2632/4885ABL1 754/4885 |
| US-11167036-B2 | Techniques for enhancing the selectivity and efficacy of antimicrobial and anticancer polymer agents | BTD, HLCS, CD47 | TDP1 3809/4885MEN1 2632/4885ABL1 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.